MEX003

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)	cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder	Recruiting	Phase 3	2026-09-29		NCT07179380
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Active, not recruiting	Phase 2 / Phase 3	2026-08-20		NCT05649748

Clinical trials